GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) » Definitions » Liabilities-to-Assets

Shan Dong Kexing Bioproducts Co (SHSE:688136) Liabilities-to-Assets : 0.47 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shan Dong Kexing Bioproducts Co Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Shan Dong Kexing Bioproducts Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,440 Mil. Shan Dong Kexing Bioproducts Co's Total Assets for the quarter that ended in Mar. 2024 was ¥3,064 Mil. Therefore, Shan Dong Kexing Bioproducts Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 was 0.47.


Shan Dong Kexing Bioproducts Co Liabilities-to-Assets Historical Data

The historical data trend for Shan Dong Kexing Bioproducts Co's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shan Dong Kexing Bioproducts Co Liabilities-to-Assets Chart

Shan Dong Kexing Bioproducts Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Liabilities-to-Assets
Get a 7-Day Free Trial 0.41 0.24 0.33 0.43 0.46

Shan Dong Kexing Bioproducts Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.45 0.44 0.46 0.47

Competitive Comparison of Shan Dong Kexing Bioproducts Co's Liabilities-to-Assets

For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shan Dong Kexing Bioproducts Co's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Shan Dong Kexing Bioproducts Co's Liabilities-to-Assets falls into.



Shan Dong Kexing Bioproducts Co Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Shan Dong Kexing Bioproducts Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Liabilities-to-Assets (A: Dec. 2023 )=Total Liabilities/Total Assets
=1400.298/3031.093
=0.46

Shan Dong Kexing Bioproducts Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 is calculated as

Liabilities-to-Assets (Q: Mar. 2024 )=Total Liabilities/Total Assets
=1439.999/3063.871
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shan Dong Kexing Bioproducts Co  (SHSE:688136) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Shan Dong Kexing Bioproducts Co Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Shan Dong Kexing Bioproducts Co's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Shan Dong Kexing Bioproducts Co (SHSE:688136) Business Description

Traded in Other Exchanges
N/A
Address
No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
Executives
Wang Xiao Qin Directors, senior managers
Cui Ning Directors, senior managers
Ma Hong Jie senior management
Shao Ke senior management
Deng Xue Qin Director
Zhao Yan Qing Directors, senior managers

Shan Dong Kexing Bioproducts Co (SHSE:688136) Headlines

No Headlines